Results 1 to 10 of about 27 (27)

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial

open access: yesBJS (British Journal of Surgery), Volume 107, Issue 13, Page 1791-1800, December 2020., 2020
Remnant cancer missed by endoscopic biopsies was located in the mucosa in two‐thirds of patients with residual disease after neoadjuvant chemoradiotherapy (nCRT). One‐third of patients had residual disease in the submucosa underneath a tumour‐free mucosa. The yield of biopsies in active surveillance after nCRT could be improved by sampling larger areas
B. J. van der Wilk   +11 more
wiley   +1 more source

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy

open access: yesBJS Open, Volume 4, Issue 4, Page 593-600, August 2020., 2020
Following propensity adjustment for stage, age and sex, neoadjuvant therapy was not associated with survival. Tumour regression is a powerful prognostic indicator, and future research should focus on identifying patients who will derive the most benefit from neoadjuvant chemotherapy.
A. G. M. T. Powell   +5 more
wiley   +1 more source

Liquid biopsy for cancer diagnosis using vibrational spectroscopy: systematic review

open access: yesBJS Open, Volume 4, Issue 4, Page 554-562, August 2020., 2020
This article provides a systematic review of analysis by vibrational spectroscopy (VS) of human blood for cancer diagnosis – a spectral ‘liquid biopsy’. VS showed high potential for cancer diagnosis, but standardized reporting methods and more robust studies are needed before its value in clinical practice can be determined.
D. J. Anderson   +3 more
wiley   +1 more source

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study

open access: yesBJS Open, Volume 4, Issue 1, Page 59-70, February 2020., 2020
After oesophagectomy for oesophageal adenocarcinoma (OAC), the 5‐year survival rate is currently only 30 per cent. There is strong observational evidence that statin use is associated with reduced all‐cause and cancer‐specific mortality in patients with OAC.
L. Alexandre   +16 more
wiley   +1 more source

UEG Week 2021 Moderated Posters

open access: yes, 2021
United European Gastroenterology Journal, Volume 9, Issue S8, Page 163-259, October 2021.
wiley   +1 more source

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus

open access: yesBJS Open, Volume 3, Issue 6, Page 767-776, December 2019., 2019
A positive circumferential resection margin (CRM) has been shown to be an adverse prognostic indicator after oesophagectomy for adenocarcinoma. Clinical tumour status, tumour volume, poor differentiation, lack of response following chemotherapy and radiological assessment of invasion can be used to predict CRM positivity in oesophageal adenocarcinoma ...
W. R. C. Knight   +30 more
wiley   +1 more source

UEG Week 2013 Poster Presentations

open access: yes, 2013
United European Gastroenterology Journal, Volume 1, Issue S1, Page A135-A587, October 2013.
wiley   +1 more source
Some of the next articles are maybe not open access.

Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas

Reumatología Clínica, 2011
Juan D Cañete   +2 more
exaly  

Home - About - Disclaimer - Privacy